ACBD6 and Miyoshi myopathy: Our research leveraging both scRNA-seq and bulk-seq data revealed significant differences in ACBD6 expression between normal and tumor tissues in MM, with high ACBD6 expression correlating with notably lower OS (p < 0.001).